Abstract
Progress toward elucidating the function of α1B-adrenergic receptors (α1BARs) in the central nervous system has been constrained by a lack of agonists and antagonists with adequate α1B-specificity. We have obviated this constraint by generating transgenic mice engineered to overexpress either wild-type or constitutively active α1BARs in tissues that normally express the receptor, including the brain. All transgenic lines showed granulovacular neurodegeneration, beginning in α1B-expressing domains of the brain and progressing with age to encompass all areas. The degeneration was apoptotic and did not occur in non-transgenic mice. Correspondingly, transgenic mice showed an age-progressive hindlimb disorder that was parkinsonian-like, as demonstrated by rescue of the dysfunction by 3, 4-dihydroxyphenylalanine and considerable dopaminergic-neuronal degeneration in the substantia nigra. Transgenic mice also had a grand mal seizure disorder accompanied by a corresponding dysplasia and neurodegeneration of the cerebral cortex. Both behavioral phenotypes (locomotor impairment and seizure) could be partially rescued with the α1AR antagonist terazosin, indicating that α1AR signaling participated directly in the pathology. Our results indicate that overstimulation of α1BAR leads to apoptotic neurodegeneration with a corresponding multiple system atrophy indicative of Shy-Drager syndrome, a disease whose etiology is unknown.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Burt, A.M. in Textbook of Neuroanatomy 367–399 (W.B. Saunders, Philadelphia, 1993).
Zuscik, M.J., Piascik, M.T. & Perez, D.M. Cloning, cell-type specificity, and regulatory function of the mouse α1B-adrenergic receptor promoter. Mol. Pharmacol. 56, 1288–1297 (1999).
Perez, D.M. et al. Constitutive activation of a single effector pathway: Evidence for multiple activation states of a G protein-coupled receptor. Mol. Pharmacol. 49, 112–122 (1996).
Hwa, J., Gaivin, R.J., Porter, J.E. & Perez, D.M. Synergism of constitutive activity in α1-adrenergic receptor activation. Biochemistry 36, 633–639 (1997).
Duteil, J. et al. Central α1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur.J.Pharmacol. 180, 49–58 (1990).
Sirvio, J. & MacDonald, E. Central α 1-adrenoceptors: Their role in the modulation of attention and memory formation. Pharmacol. Ther. 83, 49–65 (1999).
Ramarao, C.S. et al. Genomic organization and expression of the human α1B-adrenergic receptor. J. Biol. Chem. 267, 21936–21945 (1992).
Haavik, J. & Toska, K. Tyrosine hydroxylase and Parkinson's disease. Mol. Neurobiol. 16, 285–309 (1998).
Palacios, J.M., Hoyer, D. & Cortes, R. α1-Adrenoceptors in the mammalian brain: Similar pharmacology but different distribution in rodents and primates. Brain Res. 419, 65–75 (1987).
Day, H.E.W., Campeau, S., Watson, S.J. Jr. & Akil, H. Expression of α1B adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J. Neurosci. 19, 10098–10106 (1999).
Ivanov, A. & Aston-Jones, G. Extranuclear dendrites of locus coeruleus neurons: activation by glutamate and modulation of activity by alpha adrenoceptors. J. Neurophysiol. 74, 2427–2436 (1995).
Kirkwood, A., Rozas, C., Kirkwood, J., Perez, F. & Bear, M.F. Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine. J. Neurosci. 19, 1599–1609 (1999).
Beani, L., Tanganelli, S., Antonelli, T. & Bianchi, C. Noradrenergic modulation of cortical acetylcholine release is both direct and γ-aminobutyric acid-mediated. J. Pharmacol. Exp. Ther. 236, 230–235 (1986).
Frandsen, A. & Schousboe, A. Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons. J. Neurochem. 60, 1202–1211 (1993).
Turner, P.R., Mefford, S., Christakos, S. & Nissenson, R.A. Apoptosis mediated by activation of the G-protein coupled receptor for parathyroid hormone (PTH)/PTH-related protein (PTHrP). Mol. Endocrinol. 14, 241–254 (2000).
Cash, R., Ruberg, M., Raisman, R. & Agid, Y. Adrenergic receptors in Parkinson's disease. Brain Res. 322, 269–275 (1984).
Gioanni, Y., Thierry, A.-M., Glowinski, J. & Tassin, J.-P. α1-Adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: Implications for the modality of action of different types of neuroleptics. Synapse 30, 362–370 (1998).
Baik, J.-H. et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424–428 (1995).
Amabeoku, G. & Chandomba, R. Strychnine-induced seizures in mice: the role of noradrenaline. Prog. Neuropsychopharmacol. Biol. Psychiatry 18, 753–763 (1994).
Briere, R. et al. α-1 Adrenoceptors are decreased in human epileptic foci. Ann. Neurol. 19, 26–30 (1985).
Jazrawi, S.P. & Horton, R.W. Brain adrenoceptor binding sites in mice susceptible (DBA/2J) and resistant (C57 Bl/6) to audiogenic seizures. J. Neurochem. 47, 173–177 (1986).
Milano, C.A., et al. Myocardial expression of a constitutively active a1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc.Natl.Acad.Sci.USA 91, 10109–10113 (1994).
Akhter, S.A., et al. Transgenic mice with cardiac overexpression of a1B-adrenergic receptors. J.Biol.Chem. 272, 21253–21259 (1997).
Cavalli, A., et al. Decreased blood pressure response in mice deficient of the a1b-adrenergic receptor. Proc.Natl.Acad.Sci.USA 94, 11589–11594 (1997).
Sallinen, J., et al. Genetic alteration of a2C-adrenoceptor expression in mice: Influence on locomotor, hypothermic and neurochemical effects of dexmedetomidine, a subtype-nonselective a2-adrenoceptor agonist. Mol.Pharmacol. 51, 36–46 (1997).
Hein, L., Limbird, L., Eglen, R.M. & Kobilka, B.K. Gene substitution/knockout to delineate the role of a2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines. Ann.N.Y.Acad.Sci. 881, 265–271 (1999).
Fahn, S., Greene, P., Ford, B. & Bressman, S.B. Parkinsonism. In: Handbook of Movement Disorders 13–48 (Current Medicine, Inc., Philadelphia, PA, 1998).
Cotecchia, S., et al. Molecular cloning and expression of the cDNA for the hamster a1-adrenergic receptor. Proc.Natl.Acad.Sci.USA 85, 7159–7163 (1988).
Domyancic, A.V. & Morilak, D.A. Distribution of a1A adrenergic receptor mRNA in the rat brain visualized by in situ hybridization. J.Comp.Neurol. 386, 358–378 (1997).
Vince, D.G., et al. Quantitative comparison of immunohistochemical staining intensity in tissues fixed in formalin and Histochoice. Anal.Cell.Pathol. 15, 119–129 (1997).
Acknowledgements
The authors thank the Cleveland Clinic Foundation Transgenic Core for doing the transgene injections that produced founder mice. Histology and immunohistochemistry were done by G. Vince and M. Garcia of the Department of Biomedical Engineering at the Cleveland Clinic Foundation Lerner Research Institute. DNA was sequenced by the Cleveland Clinic Sequencing Core. This work was funded by RO1HL61438 (D.M.P.), F32HL1000402 (M.J.Z.), an American Heart Established Investigator Award (D.M.P.) and an unrestricted research grant from Glaxo Wellcome (D.M.P.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zuscik, M., Sands, S., Ross, S. et al. Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy. Nat Med 6, 1388–1394 (2000). https://doi.org/10.1038/82207
Issue Date:
DOI: https://doi.org/10.1038/82207
This article is cited by
-
The genetic basis of multiple system atrophy
Journal of Translational Medicine (2023)
-
Animal models of multiple system atrophy
Clinical Autonomic Research (2015)
-
Long-term α1B-adrenergic receptor activation shortens lifespan, while α1A-adrenergic receptor stimulation prolongs lifespan in association with decreased cancer incidence
AGE (2014)
-
Involvement of the α1D-adrenergic Receptor in Methamphetamine-Induced Hyperthermia and Neurotoxicity in Rats
Neurotoxicity Research (2013)
-
Modelling progressive autonomic failure in MSA: where are we now?
Journal of Neural Transmission (2011)